Back to search

Peptide record

TPDB41441

di-PST13-RK-C Anticancer standard
28 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41441
di-PST13-RK-C
Anticancer
Cancer-related peptides
ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF pep-lab
standard
No
A 28-aa standard natural anticancer peptide sequence curated from ACP740 _ACP240, AntiCP 2.0, CancerPPD 2.0, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
KKKFPWWWPFKKKCKKKFPWWWPFKKKC-NH2
Physicochemical Analysis
C200H280N46O29S2
ARNDEQGHILMSTYV
K
3856.83
10.99
12
0
10
+12
-2.42
-1.514
0.00
Mammalian: 1.3 hour Yeast: 3 min E.coli: 2 min
33125
858.86
2
Residue Composition
number
0
A
0
R
0
N
0
D
2
C
0
E
0
Q
0
G
0
H
0
I
0
L
12
K
0
M
4
F
4
P
0
S
0
T
6
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 0 N: 0 D: 0 C: 2 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 12 M: 0 F: 4 P: 4 S: 0 T: 0 W: 6 Y: 0 V: 0
Chemical Descriptors
28
C200H280N46O29S2
3856.83
10.99
+12
-2.42
-1.514
Amidation
L
Linear
Free
Antimicrobial
Derivative of tritrpticin
Evidence Records 2 records
Evidence 1 Activity

Activity

IC50
IC50 =17 µg/ml
Anticancer
17 µg/mL

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

IC50
IC50 =17 µg/ml
Anticancer
17 µg/mL

Target

Breast Cancer
MDA-MB-361
Breast

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2008